• Aligos Therapeutics selects drug candidate ALG-097558, a potent ritonavir-free oral protease inhibitor for the treatment and prevention of COVID-19

    Tuesday April 5th 2022

  • Kantify announces its new breakthrough AI technology for drug discovery

    Thursday March 31st 2022

  • Solvay Brussels School of Economics and Management joins forces with the Belgian life sciences ecosystem to train the next generation of Biotech and MedTech leaders

    Thursday March 31st 2022

  • V-Bio Ventures raises EUR 110 million for its second fund and expands team

    Thursday March 31st 2022

  • Biotalys appoints Carlo Boutton as Chief Scientific Officer

    Thursday March 31st 2022

  • BioStrand announces acquisition by IPA

    Wednesday March 30th 2022

  • flanders.bio lanceert vernieuwde vacaturebank voor life sciences

    Wednesday March 30th 2022

  • miDiagnostics welcomes Nicolas De Clercq as its new Chief Financial Officer

    Wednesday March 30th 2022

  • Your news here?

  • Rejuvenate Biomed started a groundbreaking clinical trial and expands for future growth

    Tuesday March 29th 2022

  • Bone Therapeutics to strategically focus on lead cell therapy product ALLOB

    Tuesday March 29th 2022

  • 2021 was a record year for Flanders’ exports

    Tuesday March 29th 2022


Strategic Partners